Cntn1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
CNTN1 (Contactin 1) encodes a neuronal cell adhesion molecule belonging to the immunoglobulin superfamily. Contactins are glycosylphosphatidylinositol (GPI)-anchored proteins that play crucial roles in neural development, myelination, and synaptic function. CNTN1 is specifically expressed in the nervous system and is essential for the formation and maintenance of neural circuits.
[^2]
| Property | Value |
|----------|-------|
| **Gene Symbol** | CNTN1 |
| **Full Name** | Contactin 1 |
| **Chromosomal Location** | 12q11-q21 |
| **NCBI Gene ID** | 1277 |
| **OMIM ID** | 600430 |
| **Ensembl ID** | ENSG00000124244 |
| **UniProt ID** | Q12866 |
| **Aliases** | CNTN, F3, Contactin-1, Neural Cell Surface Protein F3 |
Contactin 1 is a GPI-anchored neuronal cell adhesion molecule with six immunoglobulin-like domains and four fibronectin type III repeats. It mediates cell-cell interactions in the nervous system through homophilic and heterophilic interactions.
- Axon guidance: CNTN1 guides developing axons to their correct targets during development
- Synapse formation: Essential for proper synapse development and function
- Myelination: Critical for interactions between axons and myelinating glial cells
- Neural circuit assembly: Mediates assembly of specific neural networks
- Node of Ranvier organization: Concentrated at paranodal regions of myelinated axons
- CNTN1 mutations have been associated with ALS
- Altered CNTN1 expression in ALS motor neurons and spinal cord
- Role in neuromuscular junction maintenance may be relevant to ALS pathogenesis
- Studies have identified CNTN1 variants in ALS patients
- CNTN1 is involved in synaptic plasticity, which is impaired in AD
- Altered expression in AD brain tissue
- May contribute to synaptic dysfunction through effects on synaptic adhesion
- Autism spectrum disorders: CNTN1 variants have been implicated
- Schizophrenia: Altered CNTN1 expression in postmortem brain
- Peripheral neuropathy: CNTN1 mutations cause inherited neuropathies
CNTN1 is primarily expressed in the nervous system:
- Cerebral cortex (pyramidal neurons)
- Hippocampus (CA regions)
- Cerebellum (Purkinje cells)
- Spinal cord (motor neurons)
- Peripheral nervous system (sensory and motor neurons)
- Paranodal regions of myelinated axons
- Biomarker potential: CNTN1 levels in CSF may serve as a biomarker
- Therapeutic target: Modulating CNTN1 function may have neuroprotective effects
- Gene therapy: AAV-mediated CNTN1 delivery being explored
[1] Shang, D. et al. (2015). CNTN1 mutations in ALS patients. Neurology 85, 1324-1331.
[2] Zhang, Y. et al. (2018). The role of CNTN1 in neurodegenerative diseases. Mol Neurobiol 55, 7828-7838.
[3] Liu, X. et al. (2019). Contactin 1 in synaptic plasticity and neurodegeneration. J Neurosci Res 97, 1452-1465.
[4] Hu, J. et al. (2020). CNTN1 expression in Alzheimer's disease brain. Brain Pathol 30, 345-356.
[5] Shimizu, H. et al. (2017). CNTN1 and peripheral neuropathy. Brain 140, 2223-2234.
The study of Cntn1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.